SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-070983
Filing Date
2014-02-27
Accepted
2014-02-27 06:17:05
Documents
4
Period of Report
2014-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d684472d8k.htm 8-K 16559
2 EX-99.1 d684472dex991.htm EX-99.1 351554
3 GRAPHIC g684472img1.jpg GRAPHIC 14143
4 GRAPHIC g684472img2.jpg GRAPHIC 7923
  Complete submission text file 0001193125-14-070983.txt   400159
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 14646624
SIC: 2834 Pharmaceutical Preparations